Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days

2017/06/22 by Christian Fuchs, C. Fuchs, S. Wauschkuhn +17 · 20 citations
Medicine · Immunology and Microbiology · #Sepsis Diagnosis and Treatment #Immune Response and Inflammation #Cardiac, Anesthesia and Surgical Outcomes

paper · pdf · doi:10.1093/bja/aex231

Cited by

• Effect of preadmission beta-blockade on mortality in multiple trauma. [europepmc]
• The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review. [europepmc]
• Sepsis With Preexisting Heart Failure: Management of Confounding Clinical Features. [europepmc]
• Is the Sympathetic System Detrimental in the Setting of Septic Shock, with Antihypertensive Agents as a Counterintuitive Approach? A Clinical Proposition. [europepmc]
• Beta-Adrenergic Blockade in Critical Illness. [europepmc]
• Comparison of ROX index (SpO 2 /FIO 2 ratio/respiratory rate) with a modified dynamic index incorporating PaO 2 /FIO 2 ratio and heart rate to predict high flow nasal cannula outcomes among patients with acute respiratory failure: a single centre retrospective study. [europepmc]
• Role of adrenergic receptors in shock. [europepmc]
• Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial. [europepmc]
• Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial. [europepmc]
• Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature. [europepmc]
• Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). [europepmc]
• Epidemiology of β-blocker use among critically iII patients during and after septic shock. [europepmc]
• Impact of early β-blocker use on the incidence of sepsis and clinical outcomes following cardiac surgery: a retrospective cohort study. [europepmc]
• Impact of β-blockers on mortality in sepsis-associated acute kidney injury: a retrospective propensity score-matched analysis. [europepmc]
• Distributive shock in cardiac intensive care unit patients. [europepmc]
• Sympathetic regulation of the host immune response to bacterial sepsis. [europepmc]
• Association of Long-Term Oral β-Blocker Use With Cardiac Troponin I and B-Type Natriuretic Peptide in Septic Myocardial Injury: A Retrospective Cohort Study. [europepmc]
• The global trends and hotspots beta-blocker therapy in sepsis and septic shock: A bibliometric analysis based on CiteSpace and VOSviewer. [europepmc]
• Effect of premorbid beta-blockers on cardiac function and clinical outcomes in septic patients: a retrospective study. [europepmc]
• Septic cardiomyopathy: Fact or fiction? [europepmc]